cytarabine has been researched along with edelfosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braquet, P; Principe, P; Sidoti, C | 1 |
| Berdel, WE; Vogler, WR | 1 |
| Vogler, WR | 1 |
| Civoli, F; Daniel, LW; Whitman, SP | 1 |
| An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 1 |
1 trial(s) available for cytarabine and edelfosine
| Article | Year |
|---|---|
Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cryopreservation; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cells; Humans; Infections; Leukemia; Life Tables; Male; Middle Aged; Neoplastic Stem Cells; Phospholipid Ethers; Salvage Therapy; Survival Analysis; Tissue Preservation; Whole-Body Irradiation | 1993 |
4 other study(ies) available for cytarabine and edelfosine
| Article | Year |
|---|---|
Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Cytarabine; DNA; Drug Screening Assays, Antitumor; Flow Cytometry; G2 Phase; Humans; Mitosis; Phospholipid Ethers; S Phase; Tumor Cells, Cultured; Vinblastine | 1992 |
Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs.
Topics: Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Phospholipid Ethers; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis; Whole-Body Irradiation | 1994 |
Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation.
Topics: Apoptosis; Biological Transport; Cytarabine; DNA Fragmentation; Down-Regulation; Enzyme Activation; HL-60 Cells; Humans; Oligonucleotides, Antisense; Phospholipid Ethers; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate | 1997 |
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility | 1986 |